Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
1qm5 | PLP | Maltodextrin phosphorylase | 2.4.1.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
1qm5 | PLP | Maltodextrin phosphorylase | 2.4.1.1 | 1.000 | |
3t3i | GPW | Glycogen phosphorylase, muscle form | 2.4.1.1 | 0.565 | |
4el5 | D1M | Glycogen phosphorylase, muscle form | 2.4.1.1 | 0.505 | |
5gpb | GPM | Glycogen phosphorylase, muscle form | 2.4.1.1 | 0.477 | |
2bpo | NAP | NADPH--cytochrome P450 reductase | / | 0.451 | |
4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
3dy8 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
3dys | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 |